TVARDI THERAPEUTICS, INC.
Returns on Capital
| Period | ROE | ROI | ROA |
|---|---|---|---|
| Mar 2013 | 4.8% | 4.8% | — |
| Jun 2013 | -11.0% | -11.0% | — |
| Sep 2013 | 8.8% | 8.8% | — |
| Dec 2013 | 3.9% | 3.9% | -11.6% |
| Mar 2014 | -5.2% | -5.2% | -4.7% |
| Jun 2014 | -5.9% | -5.9% | -5.3% |
| Sep 2014 | -11.8% | -11.8% | -10.5% |
| Dec 2014 | -8.1% | -8.1% | -7.5% |
| Mar 2015 | -9.9% | -9.9% | -9.1% |
| Jun 2015 | -13.4% | -13.4% | -12.2% |
| Sep 2015 | -4.2% | -4.2% | -4.1% |
| Dec 2015 | -9.1% | -9.1% | -8.6% |
| Mar 2016 | -11.3% | -11.3% | -10.5% |
| Jun 2016 | -15.8% | -15.8% | -14.2% |
| Sep 2016 | -16.1% | -16.1% | -14.4% |
| Dec 2016 | -43.3% | -43.3% | -34.4% |
| Mar 2017 | -75.9% | -75.9% | -51.3% |
| Jun 2017 | -8.5% | -8.5% | -7.9% |
| Sep 2017 | -12.6% | -12.6% | -11.5% |
| Dec 2017 | -16.3% | -16.3% | -14.6% |
| Mar 2018 | -23.3% | -23.3% | -20.8% |
| Jun 2018 | -23.5% | -23.5% | -12.3% |
| Sep 2018 | -13.0% | -13.0% | -9.1% |
| Dec 2018 | -15.5% | -15.5% | -10.8% |
| Mar 2019 | -19.2% | -19.2% | -12.9% |
| Jun 2019 | -23.1% | -23.1% | -15.3% |
| Sep 2019 | -15.5% | -15.5% | -12.4% |
| Dec 2019 | -15.3% | -15.3% | -12.3% |
| Mar 2020 | -18.0% | -18.0% | -14.7% |
| Jun 2020 | -17.8% | -17.8% | -14.9% |
| Sep 2020 | -12.9% | -12.9% | -11.2% |
| Dec 2020 | 31.7% | 31.7% | 29.1% |
| Mar 2021 | -10.1% | -10.1% | -9.3% |
| Jun 2021 | -15.1% | -15.1% | -13.9% |
| Sep 2021 | -0.5% | -0.5% | -0.5% |
| Mar 2022 | -13.6% | -13.6% | -12.4% |
| Jun 2022 | -2.1% | -2.1% | -1.9% |
| Sep 2022 | -12.5% | -12.5% | -10.9% |
| Mar 2023 | -19.5% | -19.5% | -17.4% |
| Jun 2023 | -28.9% | -28.9% | -23.4% |
| Sep 2023 | -32.7% | -32.7% | -24.3% |
| Mar 2024 | 6.3% | 6.3% | -4.7% |
| Jun 2024 | 9.5% | 9.5% | -9.6% |
| Sep 2024 | 7.0% | 7.0% | -10.7% |
| Mar 2025 | 9.5% | 9.5% | -24.6% |
| Jun 2025 | 12.7% | 12.7% | 9.5% |
| Sep 2025 | -19.8% | -19.8% | -14.2% |
| Mar 2026 | -46.9% | -46.9% | -26.4% |
| Jun 2026 | -77.0% | -77.0% | -36.9% |